A multidimensional chromatographic method has been applied for the differential analysis of proteins from different strains of Escherichia coli bacteria. Proteins are separated in the first dimension using chromatofocusing (CF) and further separated by nonporous reversed-phase high-performance liquid chromatography (NPS-RP-HPLC) in the second dimension. A 2-dimensional (2-D) expression map of bacterial protein content is created for virulent O157:H7 and nonvirulent E. coli strains depicting protein isoelectric point (pI) versus protein hydrophobicity. Differentially expressed proteins are further characterized using electrospray/ionization time-of-flight mass spectrometry (ESI-TOF-MS) for intact protein molecular weight (MW) determination and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) peptide mass fingerprinting for protein identification. Using this method, no significant differential protein expression is exhibited between
INTRODUCTION
Escherichia coli O157:H7 is a virulent strain of E. coli bacteria. A major contributor to food-borne illness, O157:H7 produces verotoxin causing hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS) (1) (2) (3) (4) . Culturing on specialized sorbitol-MacConkey (SMAC) agar media remains the classical method for detecting E. coli O157:H7. The lengthy procedure, however, exhibits only moderate specificity and routinely requires further confirmation (2, 4) . Complete genome sequence comparisons between E. coli O157:H7 strains and normal E. coli strains have been performed by several groups (5-7). Several O157:H7-related virulence proteins and factors are predicted from open reading frames. However, no further verification of actual gene products has been performed.
Consequently, the analysis of differential protein expression between normal and pathogenic O157:H7 E. coli is essential for further elucidation of the infection pathway, development of disease treatment options, and controlling environmental sources of contagion.
Proteomics provides a means to explore static genomes by analyzing the dynamics of protein expression. Traditionally, 2-dimensional polyacrylamide gel electrophoresis (2-D PAGE) has been the method of choice for separating complex mixtures of proteins (8) . However, limitations of 2-D PAGE technology have motivated proteomics researchers to hasten the development of liquid phase methods compatible with mass spectrometry (MS) for separating intact proteins. Established chromatographic theory demonstrates that 2-D system peak capacity is enhanced through utilization of orthogonal dimensions of separation (9) (10) (11) . While 2-D liquid chromatography (2-D LC) has yet to gain widespread popularity as an established proteomic tool, several 2-D liquid separation systems have demonstrated applicability to intact protein separations (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . The following research will discuss chromatofocusing (CF) using anion-exchange chromatography coupled with nonporous reversed-phase high-performance liquid chromatography (NPS-RP-HPLC) (27) (28) (29) for the separation of intact proteins in E. coli bacterial lysates. A major benefit of the 2-D LC technique discussed herein over traditional 2-D PAGE analysis is the capability to provide highly reproducible separations for interlysate comparisons among multiple protein sample pools.
CF is a protein separation technique first described by Sluyterman and coworkers (30) (31) (32) (33) (27) (28) (29) (34) (35) (36) (37) (38) . A major benefit of using CF as a first dimension of separation over other chromatographic methods is that CF provides essential information about separated proteins (i.e., their pIs). Protein pI is extensively utilized in protein databases as a protein identification parameter. Each pI fraction from CF is further separated by NPS-RP-HPLC, and the entire 2-D LC separation is visualized in a convenient format similar to a gel with dimensions of pI and hydrophobicity. In this work, two O157:H7 strains and one general E. coli strain are comparatively studied. Entire bacterial lysates are analyzed by 2-D LC using CF in the first dimension followed by NPS-RP-HPLC in the second dimension. Individual proteins are subsequently identified using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF-MS) peptide mass fingerprinting and off-line electrospray/ ionization time-of-flight mass spectrometry (ESI-TOF-MS) for intact protein molecular weight (MW) determination. 2-D LC protein expression maps are generated for each bacterial sample. The 2-D maps, as well as the differential display maps, are utilized to produce an accurate comparison of protein expression in the different E. coli strains.
MATERIALS AND METHODS

Bacteria Culture
E. coli 88-0447 (O136STa) and the E. coli O157:H7 strains 96-0107 (nonmotile) and 96-0112 were purchased from the Pennsylvania State University E. coli Reference Center, Wiley Lab, Orchard Road, University Park, PA.
Isolation and Cultivation
Using sterile forceps and aseptic technique, a tryptic soy agar (TSA) plate is streaked 3 times on a 1/3 quadrant with a sterile disposable loop. The inverted plate is placed in an incubator at 37°-41.5°C for 16-20 h. Using a sterile disposable loop, 2 to 3 of the most isolated colonies (preferably from quadrant 3) are picked up and streaked onto the upper 1/3 quadrant of a fresh TSA plate. Using a fresh loop, the same procedure is performed to streak for isolation into 2 additional 1/3 quadrants. The inverted plate is placed in an incubator at 37°-41.5°C for [16] [17] [18] [19] [20] 
Sample Preparation
A 0.2-to 0.3-g cell pellet is resuspended in 0.4 mL of 50 mM Tris-HCl (pH 7.8) (Sigma, St. Louis, MO, USA) and vortex mixed vigorously. The solution is sonicated twice on ice for 30 s with a 1-min interval. The lysate is subsequently mixed with 1.6 mL of buffer containing 6 M urea, 2 M thiourea, 10% (v/v) glycerol, 50 mM Tris-HCl, 2% (w/v) n-octyl-β−D-glucopyranoside (OG), 5 mM tri(2-carboxyethyl)phosphine hydrochloride (TCEP), and 1 mM of protease inhibitor cocktail (for general use) (all from Sigma). The solution is then centrifuged at 2000× g using the Marathon Micro H centrifuge for 60 min. The supernatant is removed and stored at -20°C until further use. Prior to CF, the bacterial lysate is desalted using a PD-10 Sephadex™ G-25 gel filtration column (Amersham Biosciences, Piscataway, NJ, USA). The sample is then eluted from the column using the CF start buffer.
Protein Quantification
The bacterial lysates are quantified using the Bradford-based protein assay (Bio-Rad, Hercules, CA, USA). Protein concentration in each cell line varies from 14-20 mg/mL. An equal amount of total protein (4.2 mg) is loaded onto the first dimension (CF) for each cell line analyzed.
Chromatofocusing
CF is performed on an HPCF-1D column (250 × 2.1 mm) (Eprogen, Darien, IL, USA) using a System Gold ® HPLC (Model 127S pump, Model 166 detector; Beckman Coulter, Fullerton, CA, USA). CF separations are monitored at UV 280 nm [absorbance units full-scale (AUFS) 0.05]. The pH gradient is generated using two buffers, an equilibration/start buffer (SB) and an elution buffer (EB). The SB is composed of 6 M urea and 25 mM BisTris (Sigma) adjusted to pH 7.15 with iminodiacetic acid (Sigma). The EB is composed of 6 M urea and 10% (v/v) Polybuffer™ 74 (Amersham Biosciences) adjusted to pH 4.0 also with iminodiacetic acid. The CF mobile phases are filtered through 0.20-µm nylon membrane filters (Corning, Corning, NY, USA) and degassed with helium. The removal of dissolved CO 2 is essential, as it can perturb the formation of the pH gradient.
Prior to sample CF, the HPCF column is washed with water for 1 h at 0.3 mL/min. The column is then equilibrated with SB for approximately 1 1/2 h at 0.3 mL/min until the pH of the effluent equaled the pH of the SB. A blank pH gradient is run, and then the column is re-equilibrated with SB. The pH of the mobile phase effluent is monitored online using a postdetector pH flow cell (Lazar Research Laboratories, Los Angeles, CA, USA) with a dead volume of about 150 µL. After sample application, the baseline is allowed to stabilize before pH gradient formation. The pH gradient is established by flowing EB over the column at 0.2 mL/min. The CF separation takes approximately 1 h. Fractions are collected every 0.2 pH U using a Model SC-100 fraction collector (Beckman Coulter). Data acquisition software is written in-house using Labview recording pH, UV at 280 nm, and fraction number.
Following CF, the column is first washed with 1 M NaCl (Sigma) at 0.5 mL/min until the baseline stabilizes and then rinsed with 100% 2-propanol at 0.2 mL/min until the baseline stabilizes. The column is then rinsed with water overnight to remove all residual salts. CF columns should be stored in 2-propanol (Sigma).
Nonporous Reversed-Phase HPLC
A System Gold HPLC is also used for the second dimension separation of each collected CF fraction. The instrument is equipped with a Model 127S solvent module and a Model 166 detector with a 15-µL analytical flow cell. All second dimension separations are monitored using a deuterium lamp at 214 nm (AUFS 1.00). Separations are performed at a 1.0 mL/min flow rate using a (33 × 4.6 mm) RP-HPLC column packed with 1.5-µm nonporous ODS-IIIE (C18) silica beads (Eprogen). The NPS-RP-HPLC separation of bacterial proteins in CF fractions is performed using gradient elution with two solvents [solvent A: MilliQ ® water (Millipore, Billerica, MA, USA) with 0.1% (v/v) trifluoroacetic acid (TFA) (Sigma); solvent B: acetonitrile (ACN) (Sigma) with 0.1% (v/v) TFA]. Mobile phases are sonicated, and helium sparged. The column temperature is maintained at 60°C using a Model 7971 column heater (Jones Chromatography, Resolution Systems, Holland, MI, USA). The gradient profile used for solvent B on the nonporous columns is as follows: 5%-25% B in 1 min, 25%-31% B in 1 min, 31%-37% B in 8 min, 37%-41% B in 8 min, 41%-67% B in 8 min, 67%-100% B in 2 min, 100% B for 1 min, and 100%-5% B in 1 min.
Fractions from the HPLC eluent are collected using a semi-automated in-house program using a Model SC-100 fraction collector. Collected peak fractions are divided for both MALDI-TOF-MS peptide mass fingerprinting analysis and intact MW analysis using ESI-TOF-MS.
Electrospray/Ionization TOF-MS
ESI-TOF-MS analyses of collected protein peak fractions are performed on a Micromass LCT™ workstation (Waters, Milford, MA, USA). Ions are generated from a z-spray source with a desolvation gas temperature of 150°C at a flow rate of approximately 450 L/h. The source is held at 100°C. The capillary voltage is +2800 V, the sample cone is +45 V, the extraction cone is +2 V, and the hexapole RF is +750 V with a DC offset of +3 V. The second hexapole is biased to -3 V, and the detector is held at -2750 V. External calibration is performed by direct infusion of a standard NaI/CsI (Sigma) solution. Fractions are infused into the source using a syringe pump (Harvard Apparatus, Holliston, MA, USA) at a flow rate of 30-50 µL/min.
Data is processed using Micromass MassLynx™ v3.4 software (Waters), and protein multiply charged umbrellas are deconvoluted using Micromass MaxEnt ® 1 software (Waters). Deconvolution is performed using a mass range of 5-85 kDa, 1 Da resolution, 0.75 Da peak width, and a 65% peak height value.
Tryptic Digestion of Nonporous Reversed-Phase HPLC Fractions
Fractions from NPS-RP-HPLC are reduced to a volume of 80 µL using a vacuum concentrator (Centrivap Concentrator; Labconco). Then 
MALDI-TOF-MS Sample Preparation and Data Acquisition
Tryptic digests are desalted and concentrated using 2-µm C18 ZipTips (Millipore) eluted into 10 µL of 60% (v/v) ACN/0.1% (v/v) TFA. An α-cyanohydroxycinnamic acid (α-CHCA; Sigma) matrix solution is prepared that contains the following internal standards: angiotensin I, adrenocorticotropic hormone (ACTH) fragment 1-17, and ACTH fragment 18-39 (all from Sigma). Internal standards permit sample spectra to be calibrated to a mass accuracy of 10-50 parts per million (ppm). A saturated solution of α-CHCA is first prepared in 100% ACN, diluted 1:4 with 60% (v/v) ACN/1% (v/v) TFA, and then internal standard peptides are added such that the concentration of these peptides in each sample spot will be approximately 50 fmol. Matrix solution (0.5 µL) and 0.5 µL of sample are spotted on the MALDI plate using a two-layer method.
The Micromass TofSpec-2E™ (Waters) is used in reflectron mode with positive polarity at an operat-RESEARCH REPORT ing voltage of 20 kV and a reflectron voltage of 24.5 kV. The pulse voltage used for delayed extraction is between 2000-2200 V at a 520 ns delay time. The matrix suppression setting was set at the maximum of 500 V. The sampling rate was 2 GHz, and each spectrum recorded was an average of 75-100 laser shots. The nitrogen laser (UV, 337 nm) was used at 50% laser coarse and 35-40 laser fine control.
Spectra are calibrated using the internal calibrants, and monoisotopic peak lists are generated and submitted to MS-Fit (http://prospector.ucsf.edu/ ucsfhtml4.0/msfit.htm) (using the SwissProt protein databases) for protein identification. Protein identifications are considered confident matches when meeting the following criteria: (i) ranked in the top three database hits; (ii) sequence coverage is >20%; and (iii) average mass error is <50 ppm.
Chemicals
All reagents are used without any further purification and are of the highest quality commercially available. All solvents are HPLC-grade, and water is purified using a MilliQ water filtration system (Millipore).
2-D Liquid Chromatography Protein Expression Mapping Software
2-D LC separations are displayed using ProteoVue™ software that was developed in cooperation between the University of Michigan and Eprogen. The ProteoVue software converts the chromatographic intensities from the NPS-RP-HPLC separation of each pH fraction from CF into a band intensity format. This produces a highly detailed map with the dimensions of hydrophobicity and pI. The 2-D LC maps can be viewed in either gray-scale or one of several colored formats where either hue or color intensity is proportional to the relative intensity of each chromatographic peak. Another software program, DeltaVue™ (Eprogen), is used for the differential analysis of corresponding fractions from two different sample sets. A differential map is achieved by point-to-point subtraction and is viewed between the two original sample sets. 
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RESULTS
Presuming that the virulent nature of E. coli O157:H7 is reflected in changes in bacterial protein expression, lysates of both normal and O157:H7 E. coli bacteria are utilized to analyze differential protein expression. Comparative analysis is performed using one normal strain (88-0447) and two virulent O157:H7 strains (96-0107 and 96-0112). Proteins from bacterial lysates are first fractionated according to their pI using CF. Subsequently, each pI fraction is further separated using NPS-RP-HPLC. A 2-D LC protein expression map is then generated using ProteoVue software, which conveniently presents the pI of the eluted protein from CF on the x-axis and the retention time, or hydrophobicity, from NPS-RP-HPLC of each protein peak on the y-axis. Figure 2 presents 2-D LC differential display protein expression maps generated using DeltaVue for all three bacterial strains. Initial observation reveals striking similarities between the maps of the two O157:H7 strains ( Figure 2C ), 96-0107, and 96-0112. Furthermore, the differential maps of both O157:H7 strains versus the normal E. coli strain (88-0447) exhibit similar differential expression ( Figure 2, A and B) . Equivalent amounts of total protein (4.2 mg) from each bacterial strain are used to create the differential maps in Figure 2 . Each bacterial lysate is pooled into 15 fractions of 0.2 pH U from pH 4.0 to 7.0 and then separated by hydrophobicity using NPS-RP-HPLC. The DeltaVue maps compare HPLC chromatograms from different samples with the same pI ranges. HPLC data sets from two samples, one sample represented in red and the other in green, are transformed into gellike images with a band and lane format, where band color intensity mirrors peak intensity from RP-HPLC. Bands on the differential image found in the center of each DeltaVue map are formed by point-to-point subtraction of corresponding lane data. In the differential map, the absence of bands indicates no differential protein expression between the samples, and the presence of colored bands suggests that protein expression of the particular band is higher in the sample of the same band color. While several differential bands are observed between 88-0447 and 96-0107 as well as between 88-0447 and 96-0112 over the pH range from 5.0 to 6.4, no strong bands appear on the differential maps between pH 4.0 and 5.0, suggesting no significant differential protein expression among these strains in this acidic range. Furthermore, the differential map between 88-0447 and 96-0107 exhibits the same pattern with minor differences in relative intensity as the differential map between 88-0447 and 96-0112. Consequently, few strong bands appear on the differential map between the two O157:H7 strains, 96-0107 and 96-0112. Additionally, differential maps reveal some higher abundance proteins present in the normal strain (88-0447) that disappear in the O157:H7 strains (96-0107 and 96-0112) and vice versa. Such proteins are investigated further as they can potentially serve as markers for distinguishing normal E. coli from virulent O157:H7 E. coli.
Since E. coli has been well studied, only potential proteins in four pI ranges (5.0-5.2, 5.2-5.4, 5.4-5.6, and 6.2-6.4) are targeted for further characterization by ESI-TOF-MS and MALDI-TOF-MS. These fractions are selected owing to clear differences displayed in differential maps between the O157:H7 strains and the normal E. coli strain. Figure 3 shows the comparative maps between the four selected pI fractions. Since the two O157:H7 strains exhibit similar overall protein expression, only one of the O157:H7 strains is compared with fractions from the normal strain (88-0447). Proteins identified by MALDI-TOF-MS peptide mass fingerprinting are labeled in Figure 3 , and corresponding ESI-TOF-MS intact molecular weight determination and differential expression information are summarized in Table 1 . Since HPLC is performed on fractions with identical pIs under the same separation conditions, differences in the second dimension relative UV intensity can be correlated to differential expression level for specific protein peaks (bands). Table 1 reveals six proteins only expressed in the normal E. coli strain and five proteins only associated with O157:H7 E. coli strains. Additionally, Table 1 catalogs twelve proteins present in O157:H7 and five proteins present in normal E. coli identified as overexpressed and three proteins present in the strains at equivalent concentrations. None of the identified proteins overexpressed in O157:H7 E. coli are found to be virulence-specific as compared with genome predictions.
However, the functions of some identified proteins, such as protein yfiE and yfiA, are not defined in the database searched. Furthermore, not all differentially expressed proteins are present at concentrations high enough to permit definitive protein identification.
Proteins expressed in only one bacteria strain can be potentially used as markers to differentiate the bacteria. Even without protein identification, a 2-D LC expression map pattern can be used independently as a fingerprint for E. coli O157:H7 detection. The 2-D LC method described herein is a powerful tool for pattern comparison between different protein pools.
DISCUSSION
A multidimensional chromatographic technique has been applied to the separation and comparison of E. coli bacteria lysates using CF coupled with NPS-RP-HPLC. The method provides a convenient 2-D map of protein expression with proteins categorized by both pI and hydrophobicity. The 2-D LC method offers a significantly higher loadability than conventional techniques while maintaining a high degree of resolution. While 0.2 pH U fractions were collected in this separation, CF is capable of 0.05 pH U fractionation. Higher loadability greatly enhances the detection of lower abundance proteins and is a necessity for multidimensional techniques aimed at separating complex samples. The superior fractionation achieved in both separation dimensions results in a higher peak capacity than conventional 2-D PAGE expression mapping. Furthermore, the exact protein pI and hydrophobicity [measured in %B (ACN)] values obtained uniquely identify a particular protein component and permit its collection for further characterization.
The use of 2-D LC mapping for analyzing protein expression has many advantages. The 2-D LC map generated by coupling CF with NPS-RP-HPLC creates a user-friendly map of protein expression that is easy to interpret and manipulate. The ProteoVue software allows the user to zoom in and out of regions of interest in order to view small details in the UV profiles. Furthermore, 
